| Product Code: ETC6744196 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Glycopeptide Antibiotics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Glycopeptide Antibiotics Market Revenues & Volume, 2021 & 2031F |
3.3 China Glycopeptide Antibiotics Market - Industry Life Cycle |
3.4 China Glycopeptide Antibiotics Market - Porter's Five Forces |
3.5 China Glycopeptide Antibiotics Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 China Glycopeptide Antibiotics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 China Glycopeptide Antibiotics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 China Glycopeptide Antibiotics Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 China Glycopeptide Antibiotics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Glycopeptide Antibiotics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in China |
4.2.2 Growing awareness about the effectiveness of glycopeptide antibiotics |
4.2.3 Rising investments in healthcare infrastructure in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory approvals for new antibiotics |
4.3.2 High cost associated with the development and production of glycopeptide antibiotics |
5 China Glycopeptide Antibiotics Market Trends |
6 China Glycopeptide Antibiotics Market, By Types |
6.1 China Glycopeptide Antibiotics Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 China Glycopeptide Antibiotics Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 China Glycopeptide Antibiotics Market Revenues & Volume, By Vancomycin, 2021- 2031F |
6.1.4 China Glycopeptide Antibiotics Market Revenues & Volume, By Dalbavancin, 2021- 2031F |
6.1.5 China Glycopeptide Antibiotics Market Revenues & Volume, By Oritavancin, 2021- 2031F |
6.1.6 China Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Glycopeptide Antibiotics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 China Glycopeptide Antibiotics Market Revenues & Volume, By Skin and Structure Infection, 2021- 2031F |
6.2.3 China Glycopeptide Antibiotics Market Revenues & Volume, By Meningitis, 2021- 2031F |
6.2.4 China Glycopeptide Antibiotics Market Revenues & Volume, By Clostridioides Difficile Infection, 2021- 2031F |
6.2.5 China Glycopeptide Antibiotics Market Revenues & Volume, By Enterocolitis, 2021- 2031F |
6.2.6 China Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Glycopeptide Antibiotics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 China Glycopeptide Antibiotics Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 China Glycopeptide Antibiotics Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 China Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Glycopeptide Antibiotics Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 China Glycopeptide Antibiotics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China Glycopeptide Antibiotics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 China Glycopeptide Antibiotics Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 China Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Glycopeptide Antibiotics Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Glycopeptide Antibiotics Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 China Glycopeptide Antibiotics Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 China Glycopeptide Antibiotics Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.5 China Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
7 China Glycopeptide Antibiotics Market Import-Export Trade Statistics |
7.1 China Glycopeptide Antibiotics Market Export to Major Countries |
7.2 China Glycopeptide Antibiotics Market Imports from Major Countries |
8 China Glycopeptide Antibiotics Market Key Performance Indicators |
8.1 Rate of adoption of glycopeptide antibiotics in China |
8.2 Number of clinical trials conducted on glycopeptide antibiotics |
8.3 Research and development expenditure in the field of glycopeptide antibiotics |
9 China Glycopeptide Antibiotics Market - Opportunity Assessment |
9.1 China Glycopeptide Antibiotics Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 China Glycopeptide Antibiotics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 China Glycopeptide Antibiotics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 China Glycopeptide Antibiotics Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 China Glycopeptide Antibiotics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Glycopeptide Antibiotics Market - Competitive Landscape |
10.1 China Glycopeptide Antibiotics Market Revenue Share, By Companies, 2024 |
10.2 China Glycopeptide Antibiotics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here